Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.19.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Schedule of segment reporting information
    Three Months Ended     Three Months Ended  
    March 31, 2019     March 31, 2018  
Revenues            
Real property operating   $ 266,626     $ 296,623  
Medical related consulting services – related party     14,260       -  
Development services and sales of developed products     3,278       11,290  
      284,164       307,913  
Depreciation and amortization                
Real property operating     40,781       32,624  
Medical related consulting services     2,940       4,006  
Development services and sales of developed products     95,410       86,749  
      139,131       123,379  
Interest expense                
Real property operating     24,658       236,986  
Medical related consulting services     -       -  
Development services and sales of developed products     -       -  
Other (a)     2,983       -  
      27,641       236,986  
Net loss                
Real property operating     98,689       237,700  
Medical related consulting services     190,070       100,132  
Development services and sales of developed products     247,782       173,474  
Other (a)     3,968,388       1,039,663  
    $ 4,504,929     $ 1,550,969  

 

Identifiable long-lived tangible assets at March 31, 2019 and December 31, 2018   March 31, 2019     December 31, 2018  
Real property operating   $ 7,868,781     $ 7,898,224  
Medical related consulting services     4,066       6,852  
Development services and sales of developed products     377,112       224,364  
    $ 8,249,959     $ 8,129,440  

 

Identifiable long-lived tangible assets at March 31, 2019 and December 31, 2018   March 31, 2019     December 31, 2018  
United States   $ 7,953,632     $ 7,898,806  
China     296,327       230,634  
    $ 8,249,959     $ 8,129,440  

 

(a) The Company does not allocate any interest expense and general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level.